VulnerabilityModified
CVE-2022-1521
A malicious actor can inject, replay, modify, and/or intercept sensitive data.
CRITICAL 9.1EPSS 1.12%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.12%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
- CVSS 3.1
- 9.1 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
- EPSS
- 1.12% probability · 64th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-284, CWE-306, CWE-862
- Affected
- illumina/local run manager
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.